GLYR1-mediated downregulation of lncRNA HSD11B1-AS1 promotes proliferation, migration, and invasion of breast cancer cells
Medical Oncology · 2025
DOI: 10.1007/s12032-025-03027-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Yingying Lei und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Nuclear Proteins, Oxidoreductases, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) play important roles in the occurrence and development of multiple cancers, but the role of lncRNAs in breast cancer has not been fully elucidated. We integrated data mining, bioinformatics analysis, and reverse transcription quantitative polymerase chain reaction (RT-qPCR) to pinpoint key lncRNAs that modulate breast cancer development. In vitro functional assays evaluated the impact of lncRNA 11β-hydroxysteroid dehydrogenase type 1-antisense RNA 1 (HSD11B1-AS1) on breast cancer cells proliferation, migration, and invasion. Interactions between HSD11B1-AS1 and Glyoxylate Reductase 1 Homolog (GLYR1) within breast cancer cells were confirmed through bioinformatics prediction, chromatin immunoprecipitation (ChIP), and dual-luciferase reporter assays. Rescue experiments substantiated the involvement of GLYR1 in breast cancer advancement through the regulation of HSD11B1-AS1. HSD11B1-AS1 is markedly downregulated in breast cancer tissues and cell lines, correlating with an unfavorable prognosis for patients. Functional assays revealed that the suppression of HSD11B1-AS1 notably amplified the proliferation, migration, and invasive capabilities of breast cancer cells. Conversely, the overexpression of HSD11B1-AS1 significantly curtailed the proliferation, migration, and invasion of breast cancer cells. Mechanistically, GLYR1 directly binds to the HSD11B1-AS1 promoter and repressess its transcription, thereby enhancing the malignant behaviors of breast cancer cells, including proliferation, migration, and invasion. GLYR1-mediated suppression of HSD11B1-AS1 drives breast cancer progression. The GLYR1/HSD11B1-AS1 axis may represent a promising avenue for diagnostic biomarkers and therapeutic intervention in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310058, China.
- School of Life Science, Zhengzhou University, Zhengzhou, 450001, China.
- Department of Critical Care Medicine, Zhejiang Medical and Health Group Hangzhou Hospital, Hangzhou, 310000, China.
- Department of Clinical Laboratory, The Affiliated Cangnan Hospital of Wenzhou Medical University, Wenzhou, 325899, China.
- Faculty of Medicine, Kaifeng University, Kaifeng, 475004, China.
- College of Life Sciences, Zhejiang University, Hangzhou, 310058, China. liangyouyang@live.cn.
Zitieren
APA
Lei, Y., Li, Y., Yu, Y., Guo, M., Qin, W., & Liang, X. (2025). GLYR1-mediated downregulation of lncRNA HSD11B1-AS1 promotes proliferation, migration, and invasion of breast cancer cells. Medical Oncology. https://doi.org/10.1007/s12032-025-03027-2
Vancouver
Lei Y, Li Y, Yu Y, Guo M, Qin W, Liang X. GLYR1-mediated downregulation of lncRNA HSD11B1-AS1 promotes proliferation, migration, and invasion of breast cancer cells. Medical Oncology. 2025. doi:10.1007/s12032-025-03027-2
BibTeX
@article{Lei2025,
author = {Lei, Yingying and Li, Yuqing and Yu, Yanyan and Guo, Meili and Qin, Wenwen and Liang, Xiaoyang},
title = {GLYR1-mediated downregulation of lncRNA HSD11B1-AS1 promotes proliferation, migration, and invasion of breast cancer cells},
journal = {Medical Oncology},
year = {2025},
doi = {10.1007/s12032-025-03027-2}
}
EUVIMED